HV

Hemanth Vudayaraju

Active Director Director DIN 06820447
DIN 06820447 First appointment Jan 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jan 2011
Shareholding value •••• Premium profile

About Hemanth Vudayaraju

Data last updated:

Hemanth Vudayaraju is a Director at Sadguruvijaya Hospitals Private Limited (since 2024), Director at Bridge Gap Hospitals Private Limited (since 2016) and Director at Davanagere Cancer Center Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Healthcare and Research And Development. The 3 current companies with reported revenue have a combined latest revenue of ₹13.49 Cr; the largest is Sadguruvijaya Hospitals Private Limited at ₹11.97 Cr (FY 2025). Earlier, Hemanth Vudayaraju was a Partner at Advaitha Health Care Llp (from 2011).

DIN 06820447
Primary Designation Director
Industry Healthcare
First Appointment 18 Jan 2011
Oldest Company Age 15 yrs
Largest company Sadguruvijaya Hospitals Private Limited · ₹11.97 Cr (FY 2025)
Combined revenue ₹13.49 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20242010₹11.97 Cr (FY 2025)Active
Bridge Gap Hospitals Private Limited U85320TG2016PTC113538
Director20 Dec 20162016₹1.51 Cr (FY 2024)Active
Director30 Nov 20172017₹6,600 (FY 2021)Active
Designated Partner05 Jul 20232023Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner18 Jan 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Davanagere Cancer Center Private Limited
Bridge Gap Hospitals Private Limited
Advaitha Health Care Llp
Sadguruvijaya Hospitals Private Limited
Premium access

Shareholding and investment profile for Hemanth Vudayaraju

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemanth Vudayaraju

Hemanth Vudayaraju currently holds 4 directorships: Sadguruvijaya Hospitals Private Limited (Director, since 30 Sep 2024, revenue ₹11.97 Cr (FY 2025)); Bridge Gap Hospitals Private Limited (Director, since 20 Dec 2016, revenue ₹1.51 Cr (FY 2024)); Davanagere Cancer Center Private Limited (Director, since 30 Nov 2017, revenue ₹6,600 (FY 2021)); Vudayaraju Infra Llp (Designated Partner, since 05 Jul 2023).

Hemanth Vudayaraju was first appointed on 18 Jan 2011 as Partner at Advaitha Health Care Llp. The most recent appointment on record is 30 Sep 2024 at Sadguruvijaya Hospitals Private Limited.

The 3 current companies of Hemanth Vudayaraju that report revenue have a combined latest revenue of ₹13.49 Cr: Sadguruvijaya Hospitals Private Limited ₹11.97 Cr (FY 2025); Bridge Gap Hospitals Private Limited ₹1.51 Cr (FY 2024); Davanagere Cancer Center Private Limited ₹6,600 (FY 2021).

Hemanth Vudayaraju held 1 earlier board appointment: Advaitha Health Care Llp (Partner, from 18 Jan 2011).

The current boards of Hemanth Vudayaraju's companies include Komaravelli Raj Kumar (Sadguruvijaya Hospitals Private Limited), Rajesh Hanumandla Khanna (Sadguruvijaya Hospitals Private Limited), Sreenivasrao Bopparaju (Sadguruvijaya Hospitals Private Limited), Srinivasa Chakravarthy Kandala (Sadguruvijaya Hospitals Private Limited), Chinnababu Anjaneya Sunkavalli (Bridge Gap Hospitals Private Limited), Kiran Kumar Naga Sita Ram Vakkalanka (Bridge Gap Hospitals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available